Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nevan Elam Insider Profile
4 Followers
Nevan Elam, SVP & Head of Pulmonary Bus at Nektar Therapeutics, holds 1.40K shares in Nektar Therapeutics (Ticker: NKTR), holds 21.68K shares in Savara (Ticker: SVRA), holds ― shares in Rezolute (Ticker: RZLT). Most recently, Nevan Elam ― shares of Nektar Therapeutics on ― for an estimated value of ―.
Nevan Elam has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Nevan Elam holds in companies
Most Profitable Insider Trade
The most profitable trade made by Nevan Elam
Nevan Elam's Trading History
Nektar Therapeutics
―
SVP & Head of Pulmonary Bus
―
$23.51K
Savara
Feb 05, 2019
Director
Informative Buy
4.12K
$28.84K
Rezolute
Jan 08, 2016
CEO, Director
Uninformative Sell
―
―
List of latest transactions for each holding click on a transaction to see Nevan Elam's performance on stock
You May Also Like
Nevan Elam insider profile FAQ
What is the percentage of profitable transactions made by Nevan Elam?
The percentage of profitable transactions made by Nevan Elam is ―.
What is the average return per transaction made by Nevan Elam?
The average return per transaction made by Nevan Elam is ―.
What stocks does Nevan Elam hold?
Nevan Elam holds: NKTR, SVRA, RZLT stocks.
What was Nevan Elam’s latest transaction?
Nevan Elam latest transaction was an Uninformative Buy of ―.
What was Nevan Elam's most profitable transaction?
Nevan Elam’s most profitable transaction was an Informative Buy of SVRA stock on February 5, 2019. The return on the trade was -67.20%.
What is Nevan Elam's role in Nektar Therapeutics?
Nevan Elam's role in Nektar Therapeutics is SVP & Head of Pulmonary Bus.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.